Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.4
Consolidated Balance Sheets - USD ($)
Oct. 31, 2021
Oct. 31, 2020
Current assets:    
Cash and cash equivalents $ 29,128,298 $ 6,417,061
Short–term investments 6,599,595 2,640,000
Prepaid expenses and other current assets 275,556 311,563
Total current assets 36,003,449 9,368,624
Operating lease right-of-use asset 253,955 54,340
Other assets 30,000
Total assets 36,257,404 9,452,964
Current liabilities:    
Accounts payable 136,196 232,368
Accrued expenses 1,094,935 901,025
Operating lease liability 39,397 55,198
Total current liabilities 1,270,528 1,188,591
Operating lease liability, non-current 220,082
Total liabilities 1,490,610 1,188,591
Commitments and contingencies (Note 7)
Shareholders’ equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 30,050,894 and 24,248,695 shares issued and outstanding, respectively 300,509 242,486
Additional paid-in capital 239,926,809 200,354,488
Accumulated deficit (204,790,018) (191,835,618)
Total shareholders’ equity 35,437,300 8,761,356
Noncontrolling interest (Note 2) (670,506) (496,983)
Total equity 34,766,794 8,264,373
Total liabilities and equity 36,257,404 9,452,964
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, value